Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation

Autor: Jonatan Tuncel, Florian Forster, Klementy Shchetynsky, Liselotte Bäckdahl, Liesu Meng, Inger Gjertsson, Norbert Hubner, Rikard Holmdahl, Michael Y. Bonner, Johan Bäcklund, Ulrika Norin, Min Yang, Jaime James, Katrin Klocke, Maria Bergquist, Gonzalo Fernandez Lahore, Diana Ekman, Carola Rintisch
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Male
T-Lymphocytes
General Physics and Astronomy
Arthritis
Autoimmunity
medicine.disease_cause
Lymphocyte Activation
Jurkat cells
Arthritis
Rheumatoid

Jurkat Cells
Mice
0302 clinical medicine
Receptor
Multidisciplinary
Endocytosis
Cell biology
Up-Regulation
medicine.anatomical_structure
Female
Signal transduction
Signal Transduction
Science
T cell
Adaptive immunity
Receptors
Antigen
T-Cell

T cells
Biology
General Biochemistry
Genetics and Molecular Biology

Article
Autoimmune Diseases
03 medical and health sciences
Downregulation and upregulation
medicine
Animals
Humans
Rheumatology and Autoimmunity
030203 arthritis & rheumatology
Reumatologi och inflammation
T-cell receptor
Immunology in the medical area
General Chemistry
medicine.disease
Rats
030104 developmental biology
Cardiovascular and Metabolic Diseases
Immunologi inom det medicinska området
Mutation
Lymph Nodes
Acyltransferases
Zdroj: Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Popis: The introduction of the CTLA-4 recombinant fusion protein has demonstrated therapeutic effects by selectively modulating T-cell activation in rheumatoid arthritis. Here we show, using a forward genetic approach, that a mutation in the SH3gl1 gene encoding the endocytic protein Endophilin A2 is associated with the development of arthritis in rodents. Defective expression of SH3gl1 affects T cell effector functions and alters the activation threshold of autoreactive T cells, thereby leading to complete protection from chronic autoimmune inflammatory disease in both mice and rats. We further show that SH3GL1 regulates human T cell signaling and T cell receptor internalization, and its expression is upregulated in rheumatoid arthritis patients. Collectively our data identify SH3GL1 as a key regulator of T cell activation, and as a potential target for treatment of autoimmune diseases.
The autoimmune disorder, rheumatoid arthritis (RA), has been associated with multiple pathophysiological factors. Here the authors show that deficiency in endophilin A2 in rodents protects them from experimental arthritis by altering T cell activation threshold and effector functions, thereby hinting a potential target for RA therapy.
Databáze: OpenAIRE